2024 Poster Presentations Coming in July

Here is a reminder of the 2023 Poster Presentations

P01: heliX® and heliXcyto Biosensors: Dissect Binding Interactions from Small Molecules to Cells in Real-Time, Presented by Antonio D., Dynamic Biosensors, Inc.

P02: ENB-003, an ETBR Antagonist, in Combination with Pembrolizumab for Refractory Advanced Solid Tumors: Topline Data from the ENBolden-101 Phase 1B Study, Presented by Sumayah J., ENB Therapeutics

P03: Machine Learning (ML)-Driven Approach for the Multiparametric Lead Optimisation of Anti-Tumour T-Cell Engagers (TCEs), Presented by Gino V., LabGenius Ltd.

P04: Automated Ex Vivo Isolation, Transduction and Expansion of CD137-Positive Tumor-Reactive T Cells on the CliniMACS Prodigy, Presented by Carina E., Miltenyi Biotec, Inc.

P05: Regulatory Insights in Translational Immuno-Oncology: Paving the Path for Effective Therapies, Presented by Maggie H., National Tsing Hua University

P06: Zoom In and Out: A Comprehensive Immunologic Evaluation of Human, Murine and Rat Samples, Presented by Krzysztof B., NUVISAN ICB GmbH

P07: Harnessing Next Generation Cytometry in Immuno-Oncology, Presented by Juliette P., NUVISAN ICB GmbH

P08: PB203: An Innovative Multi-Specific Fc Fusion Protein Simultaneously Targeting PD-L1, VEGF-A, and PlGF for Enhanced Cancer Treatment, Presented by Hyungul Y., Panolos Bioscience, Inc.

P09: Whole Tissue Autologous Therapeutic Vaccines Safety Profile A Century Without Autoimmunity, Presented by Garrett G., Rutgers University

P10: Autologous Therapeutic Vaccine for Stage IV Metastatic Colon Cancer: A Case Report, Presented by James O., Rutgers University

P11: Autologous Therapeutic HIV Vaccine: A Phase I Trial in 10 Patients, Presented by Anthony S., Rutgers University